PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 200 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $620,000 | +30.0% | 13,592 | +6.8% | 0.01% | +44.4% |
| Q3 2017 | $477,000 | -22.2% | 12,728 | -1.0% | 0.01% | -35.7% |
| Q2 2017 | $613,000 | +18.6% | 12,861 | +13.3% | 0.01% | +7.7% |
| Q1 2017 | $517,000 | +49.0% | 11,354 | +5.5% | 0.01% | +62.5% |
| Q4 2016 | $347,000 | -14.3% | 10,761 | -9.2% | 0.01% | -20.0% |
| Q3 2016 | $405,000 | +5.2% | 11,845 | +3.6% | 0.01% | -9.1% |
| Q2 2016 | $385,000 | -25.1% | 11,429 | +17.4% | 0.01% | -31.2% |
| Q1 2016 | $514,000 | -16.4% | 9,733 | +21.3% | 0.02% | -20.0% |
| Q4 2015 | $615,000 | +3743.8% | 8,024 | +1838.2% | 0.02% | +1900.0% |
| Q3 2015 | $16,000 | -23.8% | 414 | +38.0% | 0.00% | 0.0% |
| Q2 2015 | $21,000 | +320.0% | 300 | +200.0% | 0.00% | – |
| Q4 2013 | $5,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,799,916 | $121,768,000 | 8.62% |
| Tamarack Advisers, LP | 625,000 | $27,044,000 | 8.22% |
| NEXTHERA CAPITAL LP | 149,086 | $6,484,000 | 5.40% |
| Spyglass Capital Management LLC | 379,609 | $16,509,000 | 5.22% |
| Gagnon Advisors, LLC | 107,412 | $4,671,000 | 2.67% |
| GAGNON SECURITIES LLC | 278,613 | $12,117,000 | 2.61% |
| Asymmetry Capital Management, L.P. | 84,735 | $3,685,000 | 2.00% |
| Rock Springs Capital Management LP | 1,250,000 | $54,363,000 | 1.97% |
| Lisanti Capital Growth, LLC | 118,620 | $5,159,000 | 1.68% |
| Elk Creek Partners, LLC | 500,069 | $21,748,000 | 1.62% |